COMBINED THERAPY FOR MUCOPOLYSACCHARIDOSIS TYPE VI (MAROTEAUX-LAMY-SYNDROME)

摘要

The present invention relates to a method for the treatment of MPS VI comprising administering an arylsulfatase B by gene therapy to a subject in need thereof, wherein said subject is administered with an arylsulfatase B enzyme replacement therapy (ERT) less frequently than once a week.